Novel methylxanthine derivative-mediated anti-inflammatory effects in inflammatory bowel disease.
about
Structure-Bioactivity Relationships of Methylxanthines: Trying to Make Sense of All the Promises and the DrawbacksNovel cancer chemotherapy hits by molecular topology: dual Akt and Beta-catenin inhibitorsRecent advancement in understanding colitis-associated tumorigenesis.Identification of Candidate Genes Related to Inflammatory Bowel Disease Using Minimum Redundancy Maximum Relevance, Incremental Feature Selection, and the Shortest-Path Approach.Body fluid biomarkers for multiple sclerosis--the long road to clinical application.High Endogenous Expression of Chitinase 3-Like 1 and Excessive Epithelial Proliferation with Colonic Tumor Formation in MOLF/EiJ Mice.A Heparin Binding Motif Rich in Arginine and Lysine is the Functional Domain of YKL-40.Increased expression of Chitinase 3-like 1 and microvessel density predicts metastasis and poor prognosis in clear cell renal cell carcinoma.Potential suppressive effects of theophylline on human rectal cancer SW480 cells in vitro by inhibiting YKL-40 expression.Xanthine scaffold: scope and potential in drug development
P2860
Q26740559-BBD95E0D-3BD0-4D2C-9499-E548EFED8476Q28546685-00D6E283-E16A-49B9-8013-4CFC00C6E829Q34390271-8B86BD68-E900-4152-A309-ACA1D7CA35B4Q37672624-BFB8DDEE-2BB7-41A0-B69F-C02DD6C11330Q38590773-03A2ACBB-7322-4AF3-917A-C297F241DCEAQ41253339-9CF7B9BB-DC90-4C62-B634-82D4D91997FBQ47254535-0F034BB4-53A0-4FCB-9C42-B9EF8715DF8FQ51061977-428F6975-094B-451A-9648-B38A2420FE9EQ55210960-E67CAC26-D929-464D-83E0-9C2513EDF827Q57298107-AEB2E40E-5F6B-4805-9D1E-43B2627539CD
P2860
Novel methylxanthine derivative-mediated anti-inflammatory effects in inflammatory bowel disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Novel methylxanthine derivativ ...... in inflammatory bowel disease.
@en
Novel methylxanthine derivativ ...... in inflammatory bowel disease.
@nl
type
label
Novel methylxanthine derivativ ...... in inflammatory bowel disease.
@en
Novel methylxanthine derivativ ...... in inflammatory bowel disease.
@nl
prefLabel
Novel methylxanthine derivativ ...... in inflammatory bowel disease.
@en
Novel methylxanthine derivativ ...... in inflammatory bowel disease.
@nl
P2093
P2860
P356
P1476
Novel methylxanthine derivativ ...... in inflammatory bowel disease.
@en
P2093
Alan Kamba
Emiko Mizoguchi
P2860
P304
P356
10.3748/WJG.V20.I5.1127
P407
P577
2014-02-01T00:00:00Z